Association between peak neutrophil count, clopidogrel loading dose, and left ventricular systolic function in...

Area of Science:

• Cardiology
• Pharmacology
• Inflammation Research

Background:

• Inflammation is critical in acute myocardial infarction (AMI) plaque development and left ventricular remodeling.
• Clopidogrel, an antiplatelet medication, may possess anti-inflammatory properties.
• High loading doses of clopidogrel have shown potential for improved clinical outcomes in AMI.

Purpose of the Study:

• To investigate the association between different clopidogrel loading doses and clinical outcomes in AMI patients.
• To evaluate the impact of clopidogrel loading dose on neutrophil levels and left ventricular function post-AMI.

Main Methods:

• Retrospective study of 357 patients with successful primary percutaneous coronary intervention for AMI.
• Patients received varying clopidogrel loading doses (300 mg, 450 mg, or 600 mg) at clinician's discretion.
• Neutrophil counts and left ventricular ejection fraction (LVEF) were assessed; logistic regression analysis was performed.

Main Results:

• Peak neutrophil levels occurred on day one post-AMI.
• Patients receiving lower clopidogrel loading doses (300 mg or 450 mg) exhibited higher peak neutrophil counts and lower LVEF (≤ 50%).
• Low clopidogrel loading dose was an independent predictor of low LVEF [OR: 1.97, 95% CI: 1.03-3.79, P = 0.04].

Conclusions:

• Low clopidogrel loading doses are associated with increased inflammation and impaired left ventricular systolic function in AMI.
• Higher clopidogrel loading doses may offer superior anti-inflammatory effects and improve left ventricular function post-AMI.
• The choice of clopidogrel loading dose is important for managing left ventricular function and inflammation in AMI patients.